CVS Health Corporation (FRA:CVS)

Germany flag Germany · Delayed Price · Currency is EUR
61.24
+0.45 (0.74%)
Last updated: Aug 26, 2025
0.74%
Market Cap77.30B
Revenue (ttm)327.26B
Net Income (ttm)3.86B
Shares Outn/a
EPS (ttm)3.06
PE Ratio20.04
Forward PE10.69
Dividend2.40 (3.90%)
Ex-Dividend DateJul 22, 2025
Volume204
Average Volume526
Open61.12
Previous Close60.79
Day's Range61.12 - 61.35
52-Week Range41.94 - 64.13
Betan/a
RSI68.62
Earnings DateJul 31, 2025

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]

Industry Health Services
Founded 1996
Employees 300,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol CVS
Full Company Profile

Financial Performance

In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.

Financial numbers in USD Financial Statements

News

CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

20 hours ago - CNBC Television

Jim Cramer talks what is driving CVS higher this year

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

20 hours ago - CNBC Television

CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

20 hours ago - CNBC

Jim Cramer talks what is driving CVS higher this year

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

21 hours ago - CNBC

Jim Cramer says CVS stock is a buy at these levels. Here's why

CNBC's Jim Cramer said he's optimistic about CVS and explained to investors why he the healthcare company's stock is worth buying

21 hours ago - CNBC

The Big 3: LLY, BA, CVS

Dan Deming considers Friday's trading action after Jerome Powell's Jackson Hole speech "remarkable." On stocks he's watching ahead, he expects Eli Lilly (LLY) to rebound off a significant sell-off, Bo...

4 days ago - Schwab Network

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now.

5 days ago - Investor's Business Daily

Only 2 Weeks Away – Register Now! Florida C-suite executives invited to HMG Strategy's 5th Annual C-Level Technology Leadership Summit on September 4

FAIRFIELD, Conn., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Save the date! C-level executives from the Sunshine State who want to find out how technology helps them reimagine their enterprise and reshape thei...

5 days ago - Benzinga

CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans

CVS Health Inc. (NYSE: CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ: GILD) new HIV prevention drug Yeztugo to its commercial plans . In June, the U.S. Food and Drug Administration (FDA) ...

5 days ago - Benzinga

CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans

CVS Health Inc. CVS said it will not add Gilead Sciences Inc.'s GILD new HIV prevention drug Yeztugo to its commercial plans.

5 days ago - Benzinga

Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medic...

5 days ago - Reuters

CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules

A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.

6 days ago - Reuters

CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules

CVS Health is not entitled to coverage from insurers, including AIG and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday.

8 days ago - Reuters

CVS shares are breaking out to the upside after a 3-year bear market cycle, according to the charts

Chart strategist Katie Stockton breaks down the technical backdrop in CVS.

8 days ago - CNBC

UBS upgrades CVS to buy rating, sees further recovery ahead

UBS analyst Kevin Caliendo's revised price target implies 15% upside ahead for shares of the health care benefit and pharmacy chain.

8 days ago - CNBC

This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...

8 days ago - Benzinga

CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?

Costco has dropped the so-called abortion pill nationwide, but it still sells Plan B, a form of contraception.

10 days ago - The Street

CVS Health Corporation (CVS) Announces Issuance of Senior Notes

CVS Health Corporation (CVS) Announces Issuance of Senior Notes

10 days ago - GuruFocus